Zhongling Luo
37 Guoxue Lane
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets.
Journal: Skeletal muscle
Published: March 15, 2024
Repurposed drug agomelatine is therapeutic against collagen-induced arthritis via iNOS targeting.
Journal: International immunopharmacology
Published: December 03, 2023
Interleukin-18 Gene Polymorphisms and Rheumatoid Arthritis Susceptibility: An Umbrella Review of Meta-Analyses.
Journal: Journal of immunology research
Published: November 10, 2023
Macrophage-derived mir-100-5p orchestrates synovial proliferation and inflammation in rheumatoid arthritis through mTOR signaling.
Journal: Journal of nanobiotechnology
Published: September 06, 2023
Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
Journal: Frontiers in immunology
Published: October 30, 2022
Acid sphingomyelinase regulates the biological functions of fibroblast-like synoviocytes.
Journal: Clinical and experimental rheumatology
Published: October 21, 2022
Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2.
Journal: International immunopharmacology
Published: September 27, 2022
Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis.
Journal: Frontiers in pharmacology
Published: September 01, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026